C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof

Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273)
05/2011
05/25/2011	EP2323681A2 Methods for treating viral disorders
05/25/2011	EP1697400B1 Biphenyl-substituted antibacterial macrocycles
05/25/2011	CN1863501B Peptide-based conditioners and colorants for hair, skin, and nails
05/25/2011	CN102076707A Caspofungin free of caspofungin impurity A
05/25/2011	CN102070703A Methods for preparing purified daptomycin
05/25/2011	CN102070702A A beta 1-10 specific binding peptide and screening method thereof
05/25/2011	CN101367867B Polypeptide for specificity detection of tubercle bacillus infection contamination and reagent kit thereof
05/25/2011	CN101265296B Reptile cathelicidin antibiotic peptide and derivatives, and application thereof
05/25/2011	CN101052651B Caspase-2 inhibitors and their biological applications
05/24/2011	US7947650 Article of manufacture
05/24/2011	US7947645 APO E analogs and methods for their use
05/24/2011	US7947458 Placental human neurokinin B precursor
05/24/2011	US7947287 Peptides for the treatment of cancer associated with the human papilloma virus (HPV) and other epithelial tumors
05/24/2011	CA2341642C Page-4, an x-linked gage-like gene expressed in normal and neoplastic prostate, testis and uterus, and uses therefor
05/24/2011	CA2337754C Recombinant multivalent malarial vaccine against plasmodium falciparum
05/24/2011	CA2264258C Novel antimicrobial peptide
05/24/2011	CA2184890C Peptides for inducing cytotoxic t lymphocyte responses to hepatitis c virus
05/19/2011	WO2011058188A1 Compounds and methods for purifying peptides produced by solid phase peptide synthesis
05/19/2011	WO2011057336A1 Antibiofilm glycopeptides
05/19/2011	WO2011057326A1 Method of treatment of type 2 diabetes
05/19/2011	WO2011037859A3 Identification of antigenic peptides from multiple myeloma cells
05/19/2011	WO2011035330A3 Oxytocin receptor agonists
05/19/2011	WO2007034490A3 Diastereomeric peptides for modulating t cell immunity
05/19/2011	US20110118440 Gamma amino acid building blocks
05/19/2011	US20110118437 Process for the Synthesis of Cyclic Heptapeptide
05/19/2011	US20110118199 Use of cns penetrating anticancer compounds for the treatment of protozoal diseases
05/19/2011	US20110118195 Methods and Compositions for the Treatment of Gastrointestinal Disorders
05/19/2011	US20110118186 Synthetic peptide amides and dimeric forms thereof
05/19/2011	US20110118184 Treatments of Gastrointestinal Disorders
05/19/2011	US20110118175 Competitive inhibitors of invariant chain expression and/or ectopic clip binding
05/19/2011	US20110118172 Metastin derivative and use thereof
05/19/2011	US20110117599 Artificial entropic bristle domain sequences and their use in recombinant protein production
05/19/2011	US20110117168 Methods and compositions for soft tissue repair
05/19/2011	US20110117167 Methods and compositions for soft tissue repair
05/19/2011	US20110117117 Novel immunogenic epitopes for immunotherapy
05/19/2011	US20110117057 Novel peptides as ns3-serine protease inhibitors of hepatitis c virus
05/19/2011	CA2780142A1 Compounds and methods for purifying peptides produced by solid phase peptide synthesis
05/18/2011	EP2322668A2 Highly conserved gene and its use to generate species-specific, genus-specific, family-specific, group-specific and universal nucleic acid probes for microorganisms.
05/18/2011	EP2322667A2 Highly conserved gene and its use to generate species-specific, genus-specific, family-specific, group-specific and universal nucleic acid probes for microorganisms.
05/18/2011	EP2322666A2 Highly conserved gene and its use to generate species-specific, genus-specific, family-specific, group-specific and universal nucleic acid probes for microorganisms.
05/18/2011	EP2322608A1 Transfection agent
05/18/2011	EP2322541A1 Gq protein competitive inhibitory polypeptides, preparation methods and uses thereof
05/18/2011	EP2322538A1 Compounds for the diagnosis of diseases associated with VCAM expression
05/18/2011	EP2322533A1 Process for producing sugar chain asparagine derivative
05/18/2011	EP2321411A1 Melk epitope peptides and vaccines containing the same
05/18/2011	EP2321341A2 Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders
05/18/2011	EP2321340A1 Novel melanoma antigen peptide and uses thereof
05/18/2011	EP2321335A1 Method for processing microbiologically produced cyclic oligopeptides
05/18/2011	EP2320932A2 Methods of predicting cancer lethality using replikin counts
05/18/2011	EP1989324B1 Pcr hot start by magnesium sequestration
05/18/2011	EP1970379B1 Non-proteolysable oligopeptides that inhibit glycoprotein gp41 of hiv
05/18/2011	EP1776133B1 Peptidic vasopressin receptor agonists
05/18/2011	EP1766011B1 Methods and uses of polypeptide ligands containing linkers
05/18/2011	CN102066410A HLA-DR binding peptides and their uses
05/18/2011	CN102066404A Angiogenic peptide
05/18/2011	CN102062780A Polypeptide immunoassay kit and detection method thereof
05/18/2011	CN102060915A Modifiable loca of human type 3 adenovirus hexon and application thereof
05/18/2011	CN102060914A Lipopeptide compound produced by bacillus marinus B-9987 and preparation and application thereof
05/18/2011	CN102060913A Heptapeptide combined with human serum albumin and application thereof
05/18/2011	CN102060912A Amyloid protein oligomer conformation type epitope polypeptide and application thereof
05/18/2011	CN102060911A Polypeptide combined with various amyloid protein monomers simultaneously and application thereof
05/18/2011	CN102060910A HLA (Human Leukocyte Antigen)-A*0201 limitation CTL (Cytotoxic T Lymphocyte) epitope of zinc translocator and application thereof
05/18/2011	CN102060909A Tumor specific target polypeptide and application thereof
05/18/2011	CN102058875A Polypeptide drug for treating human condyloma acuminatum
05/18/2011	CN102058874A Polypeptide vaccine for treating tumors caused by human papillomavirus 16
05/18/2011	CN102058873A Polypeptide drug for treating diseases caused by highly pathogenic avian influenza virus H5N1
05/18/2011	CN101372504B Method for purifying desmopressin
05/18/2011	CN101362794B B cell epitope of follicle-stimulating hormone receptor and antigen peptides containing thereof
05/18/2011	CN101328207B Citrus fruit fly antibacterial peptide, preparation and use thereof
05/18/2011	CN101284149B Polypeptides blood vessel tissue engineering matrix materials and application thereof
05/17/2011	US7943728 Polypeptides and/or polynucleotides selective for alpha v beta 3 integrin; osteoporosis, bone tumor or cancer growth, angiogenesis, Paget's disease, rheumatic arthritis, osteoarthritis; culture biosynthesis and chromatographic separation
05/17/2011	US7943574 Cell-permeable peptide inhibitors of the JNK signal transduction pathway
05/17/2011	US7943345 Methods, systems and reagents for improved immunodetection
05/12/2011	WO2011057272A1 Treatments for gastrointestinal disorders
05/12/2011	WO2011057029A1 Positively charged species as binding reagents in the separation of protein aggregates from monomers
05/12/2011	WO2011056644A2 Anti-glp-1r antibodies and their uses
05/12/2011	WO2011055980A2 Composite of a protein comprising zinc oxide-bonding peptides and zinc oxide nanoparticles, and use thereof
05/12/2011	WO2011054285A1 Melanocortin receptor agonist, preparation method and use thereof
05/12/2011	WO2011003062A3 Probiotic compositions and processes thereof
05/12/2011	WO2010146420A3 Synthetic oligopeptides designed from mite cysteine proteases and methods for the production of igy polyclonal antibodies for the detection of intradomiciliary mites
05/12/2011	US20110113495 Screening method for agents suitable for prophylaxis and therapy of alzheimer's disease (ad)
05/12/2011	US20110111445 Peptide for Determining Actin Structures in Living Cells
05/12/2011	US20110111393 PNA Probes, Mixtures, Methods And Kits Pertaining To The Determination Of Mycoplasma and related Mollicutes
05/12/2011	US20110111391 Newly identified human rhinovirus of hrv-c and methods and kits for detecting hrv-cs
05/12/2011	US20110111043 Peptides and their use as carriers into cancer cells
05/12/2011	US20110110965 Compositions that induce t cell help
05/12/2011	US20110110954 Anthrax compositions and methods of use and production
05/12/2011	US20110110922 Wound Healing Peptides and Methods of Use Thereof
05/12/2011	US20110110875 Angiogenic peptide
05/12/2011	US20110110855 Novel ghrelin analogues
05/12/2011	CA2779846A1 Positively charged species as binding reagents in the separation of protein aggregates from monomers
05/12/2011	CA2779482A1 Treatments for gastrointestinal disorders
05/11/2011	EP2319526A1 Tdf-related compounds and analogs thereof
05/11/2011	EP2319523A1 Serine protease inhibitors
05/11/2011	EP2318431A2 Recombinant pokeweed antiviral proteins, compositions and methods related thereto
05/11/2011	EP2318429A2 Prominin-1 peptide fragments and uses thereof
05/11/2011	EP2318428A1 Anticancer compounds
05/11/2011	EP1415162B1 Novel peptides for the diagnosis of schizophrenia
05/11/2011	CN102056939A Restoration of estrogen receptor-alpha activity
05/11/2011	CN102050868A H1N1 swine influenza virus hemagglutinin imitating epitope and application thereof

1 ... 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 ... 423